Showing results (11-20 of 121) with videos related to
Sort By:
Pageof 13
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2022
QuickStroop, a Shortened Version of EncephalApp, Detects Covert Hepatic Encephalopathy With Similar Accuracy Within One MinuteChathur Acharya, Jawaid Shaw, Nikki Duong, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 9, 2017
Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantationChathur Acharya, James B Wade, Andrew Fagan, et al.Hepatology Communications|July 17, 2022
Substance-use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathyChathur Acharya, Sara McGeorge, Andrew Fagan, et al.Mammalian Genome : Official Journal of the International Mammalian Genome Society|March 30, 2016
Old cells, new tricks: chromatin structure in senescenceAled John Parry, Masashi NaritaPancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 3, 2014
Hypothermia slows sequential and parallel steps initiated during caerulein pancreatitisVivek Mishra, Krutika Patel, Ram N Trivedi, et al.Hepatology (Baltimore, Md.)|June 24, 2025
Health information technology interventions reduce avoidable readmissions in cirrhosis: The HEROIC randomized controlled trialJawaid Shaw, Chathur Acharya, Andrew Fagan, et al.Journal of Clinical and Experimental Hepatology|June 13, 2018
Patient Acceptance of Lactulose Varies Between Indian and American Cohorts: Implications for Comparing and Designing Global Hepatic Encephalopathy TrialsSahaj Rathi, Andrew Fagan, James B Wade, et al.Digestive Diseases and Sciences|March 2, 2025
Utility of Advanced Age as a Predictor of Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic ShuntGavisha Waidyaratne, Sajid Jalil, Alex Liu, et al.Alimentary Pharmacology & Therapeutics|March 28, 2024
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetesMohamed I Elsaid, Na Li, Stephen A Firkins, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|August 18, 2018
Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosisJasmohan S Bajaj, Payam Matin, Melanie B White, et al.Pageof 13